Explosive Detection Equipment Market to Grow by USD 2.68 Billion (2024-2028), with AI Revolutionizing the Landscape and Rising Passenger Traffic Driving Demand – Technavio
NEW YORK, Oct. 15, 2024 /PRNewswire/ — Report with market evolution powered by AI- The global explosive detection equipment market size is estimated to grow by USD 2.68 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 7.08% during the forec
AI Drives Growth in Galvanized Steel Market, Expected to Increase by USD 51.2 Billion (2024-2028) Amid Economic Expansion in China and India
NEW YORK, Oct. 15, 2024 /PRNewswire/ — Report with market evolution powered by AI- The global galvanized steel market size is estimated to grow by USD 51.2 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of about 5.34% during the forecast period. E
Timing Devices Market to Grow by USD 2.07 Billion from 2024-2028, Fueled by Smartphone Adoption and AI-Powered Insights, Says Technavio
NEW YORK, Oct. 15, 2024 /PRNewswire/ — Report on how AI is driving market transformation- The global timing devices market size is estimated to grow by USD 2.07 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of about 6.1% during the forecast period.
The In-Plant Logistics for Automobile OEMs market is projected to grow by USD 557.8 million from 2024-2028, driven by AI and automated guided vehicles (AGVs)
NEW YORK, Oct. 15, 2024 /PRNewswire/ — Report with the AI impact on market trends- The global in-plant logistics for automobile oems market size is estimated to grow by USD 557.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 4.5% durin
Avirmax Biopharma Inc. to Exhibit Development of Next Generation Gene Therapies for Ocular Diseases at the AAO 2024 Annual Meeting in Chicago
HAYWARD, Calif., Oct. 15, 2024 /PRNewswire/ — Avirmax Biopharma Inc. (ABI) team will attend AAO 2024, the American Academy of Ophthalmology’s annual meeting in Chicago, October 17-21, 2024. Avirmax will exhibit at booth #5357 to showcase the latest progress of the ABI gene therapy ocula
Easily recyclable large-capacity transparent containers are coming: SK chemicals launches ‘ECOTRIA CLARO 300’ with improved recyclability
Enables large-capacity container production while improving transparency and recyclabilityTargeting large-capacity bottle market of 2 liters or more••• Aims to achieve sales of 30,000 tons in EBM market SEONGNAM, South Korea, Oct. 16, 2024 /PRNewswire/ — SK chemicals strengthens its Su
The First MINISH Seminar Held in Jakarta
JAKARTA, Indonesia and SEOUL, South Korea, Oct. 16, 2024 /PRNewswire/ — MINISH Dental Hospital Korea, the largest of the MINISH clinics under MINISH Technology Inc., has announced that it will host its inaugural seminar on November 6 at the Gunawarman Hotel in Jakarta, Indonesia. The event,
The First MINISH Seminar Held in Jakarta
JAKARTA, Indonesia and SEOUL, South Korea, Oct. 16, 2024 /PRNewswire/ — MINISH Dental Hospital Korea, the largest of the MINISH clinics under MINISH Technology Inc., has announced that it will host its inaugural seminar on November 6 at the Gunawarman Hotel in Jakarta, Indonesia. The event,
Easily recyclable large-capacity transparent containers are coming: SK chemicals launches ‘ECOTRIA CLARO 300’ with improved recyclability
Enables large-capacity container production while improving transparency and recyclability Targeting large-capacity bottle market of 2 liters or more••• Aims to achieve sales of 30,000 tons in EBM market SEONGNAM, South Korea, Oct. 16, 2024 /PRNewswire/ — SK chemicals strengthens its S
Avirmax Biopharma Inc. to Exhibit Development of Next Generation Gene Therapies for Ocular Diseases at the AAO 2024 Annual Meeting in Chicago
HAYWARD, Calif., Oct. 15, 2024 /PRNewswire/ — Avirmax Biopharma Inc. (ABI) team will attend AAO 2024, the American Academy of Ophthalmology’s annual meeting in Chicago, October 17-21, 2024. Avirmax will exhibit at booth #5357 to showcase the latest progress of the ABI gene therapy ocula
